To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
 
  •  

Infosys partners with Georgia Institute of Tech

Infosys partners with Georgia Institute of Tech
Bangalore, Jun 9: IT giant, Infosys is partnering with a US institute to establish a research institution in Karnataka's capital and the IT hub of India, Bangalore.

With its partnership with Georgia Institute of Technology, Infosys aims at setting up centres for excellence in information technology and information systems, energy systems, biotechnology and infrastructure studies here.

The deal was sealed when Infosys Chief Executive Officer (CEO) Kris Gopalakrishnan and Georgia Tech's provost and vice president for academic affairs Gary Schuster signed a memorandum of understanding (MoU) recently, Infosys said in a statement on Tuesday, Jun 8.

Infosys will collaborate on research projects of mutual interest in these areas of technology.

"Infosys has been collaborating with leading universities and research institutions across the globe, working with some of the best and brightest minds to develop and nurture ecosystems of research and innovation. Our association with Georgia Tech and the research programmes we undertake will focus on emerging technologies to develop client-specific business solutions," Gopalakrishnan said.

Due to the company's growing presence in Atlanta and Hyderbad, the locations have emerged as collaborative opportunities.

"Georgia Tech is exploring the possibility of establishing a small, high quality post-graduate research institution in Hyderabad. The proposed Georgia Tech facility will include centres for excellence in information technology and information systems, energy systems, biotechnology and infrastructure studies," the company statement added.

OneIndia News

 
Connect with

Q4: Infosys net profit at Rs 1,617 crore

Mumbai, Apr 13: Infosys Technolgies on Tuesday, Apr 13, reported a 0.25 percent growth in the net profit at Rs 1,617 crore during the fourth quarter ended Mar 31, 2010.The company in a filing to the Bombay Stock Exchange said,.....

Biotechnology major Biocon forays into nephrology space

Bangalore, Mar 09:  Biotechnology major Biocon on Thursday forayed into the nephrology space with the launch of a portfolio of five renal therapy products for the domestic and global markets, which it said was cheaper compared to MNC drug prices. The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category, the company's Marketing Head Rakesh Bamzai said.The Bangalore-headquartered company's Chairman and Managing Director, Kiran Mazumdar-Shaw said.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login